Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation

Molecular Cancer Research

Volumn 5, Issue 9, 2007, Pages 899-907

  Goulet, Brigitte ^a   Sansregret, Laurent ^a,b   Leduy, Lam ^a   Bogyo, Matthew ^e   Weber, Ekkehard ^d   Chauhan, Shyam S ^c   Nepveu, Alain ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CATHEPSIN L; CCAAT BINDING FACTOR; CYSTEINE PROTEINASE; ISOPROTEIN; SIGNAL PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL CYCLE S PHASE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GLYCOSYLATION; HUMAN; HUMAN CELL; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION;

3T3 CELLS; ANIMALS; BREAST NEOPLASMS; CATHEPSINS; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE ENDOPEPTIDASES; ENZYME PRECURSORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE;

EID: 34548689404     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0160     Document Type: Article

References (59)

1. Ehrmann M, Clausen T. Proteolysis as a regulatory mechanism. Annu Rev Genet 2004;38:709-24.
2. Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000; 100:391-8.
3. Goulet B, Nepveu A. Complete and limited proteolysis in cell cycle progression. Cell Cycle 2004;3:986-9.
4. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 2001;270:1-15.
5. Ellis T, Gambardella L, Horcher M, et al. The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle. Genes Dev 2001;15:2307-19.
6. Sinclair AM, Lee JA, Goldstein A, et al. Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. Blood 2001;98:3658-67.
7. Luong MX, van der Meijden CM, Xing D, et al. Genetic ablation of the CDP/Cux protein C terminus results in hair cycle defects and reduced male fertility. Mol Cell Biol 2002;22:1424-37.
8. Moon NS, Premdas P, Truscott M, Leduy L, Berube G, Nepveu A. S phase-specific proteolytic cleavage is required to activate stable DNA binding by the CDP/Cut homeodomain protein. Mol Cell Biol 2001;21:6332-45.
9. Truscott M, Raynal L, Premdas P, et al. CDP/Cux stimulates transcription from the DNA polymerase a gene promoter. Mol Cell Biol 2003;23:3013-28.
10. Sansregret L, Goulet B, Harada R, et al. The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase. Mol Cell Biol 2006;26:2441-55.
11. Holthuis J, Owen TA, van Wijnen AJ, et al. Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science 1990;247:1454-7.
12. van Wijnen AJ, van Gurp MF, de Ridder MC, et al. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F. Proc Natl Acad Sci U S A 1996;93:11516-21.
13. Cadieux C, Fournier S, Peterson AC, Bédard C, Bedell BJ, Nepveu A. Transgenic mice expressing the p75 CDP/Cux isoform develop a myeloproliferative-disease like myeloid leukemia. Cancer Res 2006;66:9492-501.
14. Goulet B, Baruch A, Moon NS, et al. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 2004;14:207-19.
15. Portnoy DA, Erickson AH, Kochan J, Ravetch JV, Unkeless JC. Cloning and characterization of a mouse cysteine proteinase. J Biol Chem 1986;261:14697-703.
16. Troen BR, Ascherman D, Atlas D, Gottesman MM. Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation. J Biol Chem 1988;263:254-61.
17. Turk B, Turk V, Turk D. Structural and functional aspects of papainlike cysteine proteinases and their protein inhibitors. Biol Chem 1997;378:141-50.
18. Kane SE, Gottesman MM. The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990;1:127-36.
19. Lah TT, Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 1998;379:125-30.
20. Chambers AF, Colella R, Denhardt DT, Wilson SM. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol Carcinog 1992;5:238-45.
21. Collette J, Ulku AS, Der CJ, Jones A, Erickson AH. Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells. Int J Cancer 2004;112:190-9.
22. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 1987;2:55-9.
23. Joseph LJ, Chang LC, Stamenkovich D, Sukhatme VP. Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts. J Clin Invest 1988;81:1621-9.
24. Kim K, Cai J, Shuja S, Kuo T, Murnane MJ. Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas. Int J Cancer 1998;79:324-33.
25. Troen BR, Chauhan SS, Ray D, Gottesman MM. Downstream sequences mediate induction of the mouse cathepsin L promoter by phorbol esters. Cell Growth Differ 1991;2:23-31.
26. Strojnik T, Zidanik B, Kos J, Lah TT. Cathepsins B and L are markers for clinically invasive types of meningiomas. Neurosurgery 2001;48:598-605.
27. Dohchin A, Suzuki JI, Seki H, Masutani M, Shiroto H, Kawakami Y. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 2000;89:482-7.
28. Park IC, Lee SY, Jeon DG, et al. Enhanced expression of cathepsin L in metastatic bone tumors. J Korean Med Sci 1996;11:144-8.
29. Chauhan SS, Goldstein LJ, Gottesman MM. Expression of cathepsin L in human tumors. Cancer Res 1991;51:1478-81.
30. Joyce JA, Baruch A, Chehade K, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004;5:443-53.
31. Gocheva V, Zeng W, Ke D, et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006;20:543-56.
32. Moon NS, Rong Zeng W, Premdas P, Santaguida M, Berube G, Nepveu A. Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas. Int J Cancer 2002;100:429-32.
33. Goulet B, Watson P, Poirier M, et al. Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells. Cancer Res 2002;62:6625-33.
34. Moon NS, Berube G, Nepveu A. CCAAT displacement activity involves Cut repeats 1 and 2, not the Cut homeodomain. J Biol Chem 2000;275:31325-34.
35. Eckert LB, Repasky GA, Ulku AS, et al. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res 2004;64:4585-92.
36. Erickson AH. Biosynthesis of lysosomal endopeptidases. J Cell Biochem 1989;40:31-41.
37. Nishimura Y, Furuno K, Kato K. Biosynthesis and processing of lysosomal cathepsin L in primary cultures of rat hepatocytes. Arch Biochem Biophys 1988; 263:107-16.
38. Nishimura Y, Kawabata T, Furuno K, Kato K. Evidence that aspartic proteinase is involved in the proteolytic processing event of procathepsin L in lysosomes. Arch Biochem Biophys 1989;271:400-6.
39. Nishimura Y, Kawabata T, Kato K. Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch Biochem Biophys 1988;261:64-71.
40. Arora S, Chauhan SS. Identification and characterization of a novel human cathepsin L splice variant. Gene 2002;293:123-31.
41. Weber E, Bahn H, Gunther D. Monoclonal antibodies against cathepsin L and procathepsin L of different species. Hybridoma 1997;16:159-66.
42. Blum G, Mulliins SR, Keren K, et al. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 2005;1:203-9.
43. De Vos J, Thykjaer T, Tarte K, et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 2002;21:6848-57.
44. Buchholz M, Braun M, Heidenblut A, et al. Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 2005;24:6626-36.
45. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-57.
46. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001;98:13790-5.
47. Korkola JE, Houldsworth J, Chadalavada RS, et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006;66:820-7.
48. Michl P, Ramjaun AR, Pardo OE, et al. CUTL1 is a target of TGFh signaling that enhances cancer cell motility and invasiveness. Cancer Cell 2005;7:521-32.
49. Cadieux C, Fournier S, Peterson AC, Bedard C, Bedell BJ, Nepveu A. Transgenic mice expressing the p75 CCAAT-displacement protein/cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia. Cancer Res 2006;66:9492-501.
50. Foekens JA, Kos J, Peters HA, et al. Prognostic significance of cathepsins B and L in primary human breast cancer. J Clin Oncol 1998;16:1013-21.
51. Thomssen C, Schmitt M, Goretzki L, et al. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. Clin Cancer Res 1995;1:741-6.
52. Premzl A, Puizdar V, Zavasnik-Bergant V, et al. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases. Biol Chem 2001;382:853-7.
53. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002;8:979-86.
54. Rios-Doria J, Day KC, Kuefer R, et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 2003;278:1372-9.
55. Wang XD, Rosales JL, Magliocco A, Gnanakumar R, Lee KY. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene 2003;22:769-74.
56. Porter DC, Zhang N, Danes C, et al. Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol 2001;21:6254-69.
57. Carragher NO, Westhoff MA, Riley D, et al. v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation. Mol Cell Biol 2002;22:257-69.
58. Coqueret O, Berube G, Nepveu A. The mammalian Cut homeodomain protein functions as a cell-cycle dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase. EMBO J 1998;17:4680-94.
59. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 1996;93:11400-6.